TRAVERE THERAPEUTICS INC. - COMMON STOCK
19.73
14-三月-25 15:45:00
15 分钟延时
股票
+0.60
+3.14%
今日范围
18.86 - 19.87
ISIN
N/A
来源
NASDAQ
-
Travere Prices Upsized $275 Million Convertible Senior Notes Offering
08 3月 2022 20:00:26 条件 Nasdaq GlobeNewswire
-
Travere Announces Proposed Convertible Senior Notes Offering
08 3月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the Barclays Global Healthcare Conference
03 3月 2022 15:30:00 条件 Nasdaq GlobeNewswire
-
28 2月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
24 2月 2022 15:01:01 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 2月 2022 16:00:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results
10 2月 2022 15:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
09 2月 2022 15:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 1月 2022 16:00:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Provides Corporate Update and 2022 Outlook
10 1月 2022 06:00:02 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Appoints Jula Inrig, M.D., as Chief Medical Officer
04 1月 2022 15:30:00 条件 Nasdaq GlobeNewswire
-
15 12月 2021 06:00:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 12月 2021 15:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at Upcoming Investor Conferences
11 11月 2021 15:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Present Abstracts at American Society of Nephrology Kidney Week 2021
02 11月 2021 15:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Third Quarter 2021 Financial Results and Organizational Progress
28 10月 2021 15:01:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Report Third Quarter 2021 Financial Results
14 10月 2021 15:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 10月 2021 16:00:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Announces Transition of Chief Medical Officer
12 10月 2021 16:00:00 条件 Nasdaq GlobeNewswire
-
15 9月 2021 15:05:00 条件 Nasdaq GlobeNewswire